IDEXX Laboratories, Inc.
IDXX
$752.88
-$3.08-0.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.59% | 21.14% | 12.27% | -7.17% | 14.53% |
| Total Depreciation and Amortization | 2.39% | 5.02% | 1.06% | -1.25% | 6.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 459.80% | -9.45% | 4.80% | 99.61% | 817.33% |
| Change in Net Operating Assets | 87.82% | -170.00% | -594.76% | 84.77% | -501.71% |
| Cash from Operations | 116.61% | -21.94% | -9.18% | 19.06% | -11.37% |
| Capital Expenditure | 8.76% | -13.57% | -2.64% | -4.15% | 15.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,002.32% | 13.94% | 103.93% | -2,651.33% | 4.27% |
| Cash from Investing | -33.43% | -13.57% | 25.68% | -45.58% | 16.83% |
| Total Debt Issued | -147.78% | 273.38% | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | 100.00% | -- |
| Issuance of Common Stock | 194.11% | 140.93% | -45.73% | 165.31% | -6.83% |
| Repurchase of Common Stock | 29.14% | 16.69% | -65.43% | -11.34% | -2.49% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.16% | 49.86% | -41.90% | 20.00% | -38.40% |
| Foreign Exchange rate Adjustments | -104.15% | 707.65% | 76.18% | -283.85% | 626.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6,882.69% | 100.50% | -510.19% | 78.09% | -2,336.08% |